|
|
| Research article summary (published 24 Dec 2007): |
Treatment of experimental autoimmune encephalomyelitis with alpha lipoic acid and associative conditioning.
Full Abstract
We have initiated studies to evaluate the suitability of performing therapeutic conditioning trials in experimental autoimmune encephalomyelitis (EAE) mice treated with alpha lipoic acid (ALA). EAE was induced in SJL mice by active immunization with myelin antigen. Once daily subcutaneous injection of ALA served as the unconditional stimulus (US) administered with the conditional stimulus (CS) saccharin-flavored drinking water under a regimen of restricted water access. In the first study, we found that water restriction and saccharin administration were compatible with disease development and effective ALA treatment of EAE mice. In the second study, mice were conditioned to once daily administration of ALA paired with administration of saccharin-flavored water (US+CS) on days 7-16. Test trials spanned experimental days 17-32 in groups receiving either saccharin-flavored water (CS, in the experimental group) versus unflavored water (CSo, in the control group) and compared several measures of EAE severity using multivariate ANOVA (MANOVA). Reduced disease severity in the experimental group (US+CS:CS) compared to the control group (US+CS:CSo) suggested that conditioning had occurred. These results demonstrate an approach for conducting therapeutic conditioning trials in EAE mice and suggest considerations for future investigations.
Learn Faster Today Improve your study skills
Author information
Author/s: Jones, Richard E (RE); Moes, Nicole (N); Zwickey, Heather (H); Cunningham, Christopher L (CL); Gregory, William L (WL); Oken, Barry (B);
Affiliation: VA Medical Center, 3710 SW Veterans Hospital Road, Portland, OR 97239, USA.
Grants: AT002656 (Agency:United States NCCAM) ; U19 AT002656-010004 (Agency:United States NCCAM) ; U19 AT002656-020004 (Agency:United States NCCAM) ; U19 AT002656-030004 (Agency:United States NCCAM)
Journal and publication information
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal: Brain, behavior, and immunity (Brain Behav Immun), published in United States. (Language: eng)
Reference: 2008-May; vol 22 (issue 4) : pp 538-43
Dates: Created 2008/04/08; Completed 2008/06/04;
PMID: 18162366, status: MEDLINE (last retrieval date: 11/6/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis.
25 Apr 2006 - Alpha-lipoic acid promotes the growth of rat hepatic pre-neoplastic lesions in the choline-deficient model.
22 Sep 2007 - GluR2-free alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors intensify demyelination in experimental autoimmune encephalomyelitis.
29 Apr 2007 - Anti-TCR antibody treatment activates a novel population of nonintestinal CD8 alpha alpha+ TCR alpha beta+ regulatory T cells and prevents experimental autoimmune encephalomyelitis.
13 May 2007 - A fusion protein consisting of IL-16 and the encephalitogenic peptide of myelin basic protein constitutes an antigen-specific tolerogenic vaccine that inhibits experimental autoimmune encephalomyelitis.
30 Jul 2007 - Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.
24 Oct 2006 - Glutamate receptors in neuroinflammatory demyelinating disease.
30 Dec 2005 - Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy.
5 Mar 2006 - Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
30 Dec 2006 - Increased transcriptional activity of milk-related genes following the active phase of experimental autoimmune encephalomyelitis and multiple sclerosis.
13 Sep 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.